|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 212 of 295 found articles
| Title: |
P-210: Oral ixazomib (Ixa), IV daratumumab (Dara), and dexamethasone (dex; IDd) in relapsed/refractory multiple myeloma (RRMM) patients (pts) with 1–3 prior therapies: phase 2 study interim analysis (IA) |
| Author: |
Orlowski, Robert Delimpasi, Sosana Straub, Jan Symeonidis, Argiris Pour, Luděk Hájek, Roman Touzeau, Cyrille Bhanderi, Viralkumar Pavlíček, Petr Robak, Pawel Berdeja, Jesus G. Matous, Jeffrey V. Karlin, Lionel Zweegman, Sonja Grosicki, Sebastian Pluta, Andrzej Kambhampati, Suman Suryanarayan, Kaveri Twumasi-Ankrah, Philip Dash, Ajeeta Labotka, Richard Dimopoulos, Meletios-Athanasios |
| Appeared in: |
Clinical lymphoma myeloma and leukemia |
| Paging: | Volume 21 () nr. S2 pages S154-S155 |
| Year: |
2021 |
| Contents: | |
| Publisher: |
Elsevier Inc. |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 212 of 295 found articles
| << previous | next >> |